TULSA-PRO®

Profound Medical is a company that specializes in developing innovative therapies for the non-invasive treatment of various diseases using a combination of magnetic resonance imaging (MRI), thermal ultrasound, and closed-loop temperature feedback control

Add to Shortlist

Features & Benefits

TULSA-PRO can be used to ablate both large and small prostates.
Ablation process is automated, precise, and predictably avoids impacting healthy tissue.
Favorable safety profile demonstrated in Phase I and TACT clinical trial data.
Actual ablation time is 1-2 cc/min; 2h total procedure time.
High-intensity directional ultrasound is used to ablate tissue.
MR suite is significantly less expensive than an operating room.
Inherently safer than outside-in ablation therapy.

Product Details

TULSA-PRO® is a medical technology designed to provide radiation-free ablation of the prostate while protecting the surrounding structures like the urethra and rectum. It offers a customizable and predictable approach to prostate ablation, allowing surgeons to define the specific volume to be treated.

TULSA-PRO® has shown potential in various applications, including intermediate stage prostate cancer, localized radio-recurrent cancer (cancer that has returned after previous treatment with radiation), retention and hematuria palliation in locally advanced prostate cancer (managing urine retention and blood in urine in advanced cases), and treating the transition zone in large volume benign prostatic hyperplasia (BPH) cases.

The technology has received the CE mark, indicating compliance with European health, safety, and environmental protection standards, and it has also obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) in August 2019. This clearance allows TULSA-PRO® to be marketed and used in the United States.